Gene · 640
Papers2,339
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 2,339
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptional Profiling and Deriving a Seven-Gene Signature That Discriminates Active and Latent Tuberculosis: An Integrative Bioinformatics Approach. | Genes (Basel) | 2022 | 35456421 | PubTator, text mining | PubMed |
| Ibrutinib in the Treatment of Solid Tumors: Current State of Knowledge and Future Directions. | Cells | 2022 | 35456016 | PubTator, text mining | PubMed |
| Combined Targeting of AKT and mTOR Inhibits Tumor Formation of EpCAM+ and CD90+ Human Hepatocellular Carcinoma Cells in an Orthotopic Mouse Model. | Cancers (Basel) | 2022 | 35454789 | PubTator, text mining | PubMed |
| MeQryEP: A Texture Based Descriptor for Biomedical Image Retrieval. | J Healthc Eng | 2022 | 35449840 | PubTator, text mining | PubMed |
| How do I diagnose Maturity Onset Diabetes of the Young in my patients? | Clin Endocrinol (Oxf) | 2022 | 35445424 | PubTator, text mining | PubMed |
| Kinase Inhibitors as Potential Therapeutic Agents in the Treatment of COVID-19. | Front Pharmacol | 2022 | 35444538 | PubTator, text mining | PubMed |
| Environmental induced transgenerational inheritance impacts systems epigenetics in disease etiology. | Sci Rep | 2022 | 35440735 | PubTator, text mining | PubMed |
| A case report of Maturity-onset diabetes of the young 12: large fragment deletion in ABCC8 gene with literature review. | Ann Transl Med | 2022 | 35434002 | PubTator, text mining | PubMed |
| Progress in treatment of neuromyelitis optica spectrum disorders (NMOSD): Novel insights into therapeutic possibilities in NMOSD. | CNS Neurosci Ther | 2022 | 35426485 | PubTator, text mining | PubMed |
| Proteolysis-targeting chimeras (PROTACs) in cancer therapy. | Mol Cancer | 2022 | 35410300 | PubTator, text mining | PubMed |
| Antiviral Effects of Animal Toxins: Is There a Way to Drugs? | Int J Mol Sci | 2022 | 35408989 | PubTator, text mining | PubMed |
| Second MAFA Variant Causing a Phosphorylation Defect in the Transactivation Domain and Familial Insulinomatosis. | Cancers (Basel) | 2022 | 35406570 | PubTator, text mining | PubMed |
| Global Transcriptomic Profiling Identifies Differential Gene Expression Signatures Between Inflammatory and Noninflammatory Aortic Aneurysms. | Arthritis Rheumatol | 2022 | 35403833 | PubTator, text mining | PubMed |
| A new finding in the key prognosis-related proto-oncogene FYN in hepatocellular carcinoma based on the WGCNA hub-gene screening trategy. | BMC Cancer | 2022 | 35397600 | PubTator, text mining | PubMed |
| SH3-domain mutations selectively disrupt Csk homodimerization or PTPN22 binding. | Sci Rep | 2022 | 35393453 | PubTator, text mining | PubMed |
| X-Chromosome Inactivation and Related Diseases. | Genet Res (Camb) | 2022 | 35387179 | PubTator, text mining | PubMed |
| Novel drug-target interactions via link prediction and network embedding. | BMC Bioinformatics | 2022 | 35379165 | PubTator, text mining | PubMed |
| Gene Variation at Immunomodulatory and Cell Adhesion Molecules Loci Impacts Primary Sjögren's Syndrome. | Front Med (Lausanne) | 2022 | 35372412 | PubTator, text mining | PubMed |
| The landscape of GWAS validation; systematic review identifying 309 validated non-coding variants across 130 human diseases. | BMC Med Genomics | 2022 | 35365203 | PubTator, text mining | PubMed |
| Robust In Vitro Pharmacology of Tmod, a Synthetic Dual-Signal Integrator for Cancer Cell Therapy. | Front Immunol | 2022 | 35359952 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/640/papers?page=26